Markets › United States › NAS › MDGL

Madrigal Pharmaceuticals Inc

NAS:MDGLHealthcareNASDAQ:NBINASDAQ:NQUSMG

$447.09−0.59%At closeAt close · Tue 20 Oct · ≈ AED 1,641.94 · Market cap $10.33B · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	—	—	96.5%	94.1%	—	—
Operating margin	—	—	—	—	−276.4%	−31.3%	−31.3%	+0.0 pts
Net margin	—	—	—	—	−258.6%	−30.1%	−30.1%	+0.0 pts
EBITDA margin	—	—	—	—	−249.9%	−27.6%	—	—
Return on equity	−84.3%	−123.3%	−149.6%	−92.2%	−61.8%	−47.8%	−47.8%	+0.0 pts
Return on assets	−70.5%	−88.5%	−81.5%	−58.3%	−44.7%	−22.9%	−22.9%	+0.0 pts
Return on capital employed	−85.8%	−123.4%	−119.0%	−72.9%	−57.0%	−31.6%	—	—
Debt / equity	0.0×	0.0×	0.3×	0.3×	0.2×	0.6×	0.6×	+0.0%
Debt / assets	0.3%	0.3%	13.8%	18.3%	11.5%	28.1%	—	—
Interest coverage	0.0×	0.0×	−74.1×	−29.9×	−33.9×	−13.5×	—	—
Current ratio	6.1×	3.5×	3.1×	5.4×	6.1×	4.0×	4.0×	+0.0%
Quick ratio	6.1×	3.5×	3.1×	5.4×	5.9×	3.8×	—	—
Cash ratio	1.2×	0.5×	2.9×	0.8×	0.6×	0.6×	0.6×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.2×	0.8×	—	—
Inventory turnover	—	—	—	—	0.2×	0.8×	—	—
Receivables turnover	—	—	—	—	3.3×	7.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—